🔴 Indaptus Therapeutics is trading 6.1% down today as it retreats from a recent rebound

Indaptus Therapeutics is trading at $2.47 (6.1% down), retreating from its recent rebound after experiencing sharp volatility in prior sessions.

• There are no fresh company-specific headlines, earnings, or clinical updates reported this morning.
• The downward move appears to reflect characteristic high volatility in a thinly traded biotech name rather than a clear new fundamental catalyst.